Hi @Snowboard
I doubt you're going to see $5M of revenue in the June quarterly report.
2 reasons for this, given the accounts show that Syntonic in the year to 31 Dec 2015 had $568K of revenue & a gross profit of $513K on that revenue (ie cost of sales were just $55K).
Deferred revenue was $148K at the same date.
Secondly it says $715K was spent on the continuation & development of the Syntonic business in Q1 & a further $400K was going to be required prior to the completion of the offer.
See investigative accounting section of the prospectus (pages 65-68 & 79) for confirmation .
http://www.asx.com.au/asxpdf/20160513/pdf/437750pxzlwjpw.pdf
So cash-burn is low and falling, yet roll-out of the product hasn't really started yet.
Not only was the $7M placing pulled they also pulled options that would have raised a further $2M at the same time.
LOTM
- Forums
- ASX - By Stock
- SYT
- Ann: Syntonic Investor Presentation-SYT.AX
Ann: Syntonic Investor Presentation-SYT.AX, page-145
-
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online